Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Market Cap	184.03B
Revenue (ttm)	75.86B
Net Income (ttm)	23.50B
Shares Out	886.45M
EPS (ttm)	26.51
PE Ratio	7.83
Forward PE	7.67
Dividend	11.00 (5.30%)
Ex-Dividend Date	Nov 24, 2024

Volume	485,301
Average Volume	226,065
Open	209.90
Previous Close	209.50
Day's Range	207.10 - 209.90
52-Week Range	197.20 - 249.80
Beta	0.16
RSI	26.65
Earnings Date	Apr 30, 2025

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, anthelmintics, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, antioxid...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 12,453
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SQURPHARMA

Financial Performance

In 2024, DSE:SQURPHARMA's revenue was 70.10 billion, an increase of 15.47% compared to the previous year's 60.71 billion. Earnings were 20.93 billion, an increase of 10.25%.